Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015, Article ID 136810, 9 pages
http://dx.doi.org/10.1155/2015/136810
Research Article

Abnormal Expression of DNA Double-Strand Breaks Related Genes, ATM and GammaH2AX, in Thyroid Carcinoma

1Department of Pathology, Zhejiang Province Cancer Hospital, Hangzhou 310022, China
2Emergency Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
3Zhejiang Cancer Research Institute, Zhejiang Province Cancer Hospital, Hangzhou 310022, China
4Department of Head and Neck Surgery, Zhejiang Province Cancer Hospital, Hangzhou 310022, China

Received 16 December 2014; Revised 11 February 2015; Accepted 5 March 2015

Academic Editor: Sabrina Corbetta

Copyright © 2015 Jin-lin Hu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 62, no. 1, pp. 10–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Davies and H. G. Welch, “Increasing incidence of thyroid cancer in the United States, 1973–2002,” The Journal of the American Medical Association, vol. 295, no. 18, pp. 2164–2167, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. R. C. Smallridge, L. A. Marlow, and J. A. Copland, “Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies,” Endocrine-Related Cancer, vol. 16, no. 1, pp. 17–44, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. P. Jackson, “Sensing and repairing DNA double-strand breaks,” Carcinogenesis, vol. 23, no. 5, pp. 687–696, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Podhorecka, A. Skladanowski, and P. Bozko, “H2AX phosphorylation: its role in DNA damage response and cancer therapy,” Journal of Nucleic Acids, vol. 2010, Article ID 920161, 9 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. O. Fernandez-Capetillo, A. Lee, M. Nussenzweig, and A. Nussenzweig, “H2AX: the histone guardian of the genome,” DNA Repair, vol. 3, no. 8-9, pp. 959–967, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Savitsky, A. Bar-Shira, S. Gilad et al., “A single ataxia telangiectasia gene with a product similar to PI-3 kinase,” Science, vol. 268, no. 5218, pp. 1749–1753, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. F. A. Derheimer and M. B. Kastan, “Multiple roles of ATM in monitoring and maintaining DNA integrity,” FEBS Letters, vol. 584, no. 17, pp. 3675–3681, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Xu, E. C. Morari, Q. Wei, E. M. Sturgis, and L. S. Ward, “Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 6, pp. 1913–1921, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. Y.-L. Zheng, O. Kosti, C. A. Loffredo et al., “Elevated lung cancer risk is associated with deficiencies in cell cycle checkpoints: genotype and phenotype analyses from a case-control study,” International Journal of Cancer, vol. 126, no. 9, pp. 2199–2210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. T. A. Buchholz, M. M. Weil, C. L. Ashorn et al., “A Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls,” Cancer, vol. 100, no. 7, pp. 1345–1351, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Angèle, A. Falconer, S. M. Edwards et al., “ATM polymorphisms as risk factors for prostate cancer development,” British Journal of Cancer, vol. 91, no. 4, pp. 783–787, 2004. View at Google Scholar · View at Scopus
  13. J. H. Barrett, M. M. Iles, and M. Harland, “Genome-wide association study identifies three new melanoma susceptibility loci,” Nature Genetics, vol. 43, no. 11, pp. 1108–1113, 2011. View at Publisher · View at Google Scholar
  14. A. Wójcicka, M. Czetwertyńska, M. Świerniak et al., “Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma,” Genes Chromosomes and Cancer, vol. 53, no. 6, pp. 516–523, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Kang, X.-Z. Deng, Y.-B. Fan, and B. Wu, “Relationships of FOXE1 and ATM genetic polymorphisms with papillary thyroid carcinoma risk: a meta-analysis,” Tumor Biology, vol. 35, no. 7, pp. 7085–7096, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. C. M. Song, T.-K. Kwon, B. L. Park, Y. B. Ji, and K. Tae, “Single nucleotide polymorphisms of ataxia telangiectasia mutated and the risk of papillary thyroid carcinoma,” Environmental and Molecular Mutagenesis, vol. 56, no. 1, pp. 70–76, 2015. View at Publisher · View at Google Scholar
  17. Y. Gu, Y. Yu, L. Ai et al., “Association of the ATM gene polymorphisms with papillary thyroid cancer,” Endocrine, vol. 45, no. 3, pp. 454–461, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Damiola, G. Byrnes, M. Moissonnier et al., “Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation,” International Journal of Cancer, vol. 134, no. 7, pp. 1659–1668, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. M. B. Kastan and D.-S. Lim, “The many substrates and functions of ATM,” Nature Reviews Molecular Cell Biology, vol. 1, no. 3, pp. 179–186, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Oka, T. Tanaka, T. Enoki et al., “DNA damage signaling is activated during cancer progression in human colorectal carcinoma,” Cancer Biology and Therapy, vol. 9, no. 3, pp. 246–252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Matthaios, P. Hountis, P. Karakitsos, D. Bouros, and S. Kakolyris, “H2AX a promising biomarker for lung cancer: a review,” Cancer Investigation, vol. 31, no. 9, pp. 582–599, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Matsuda, T. Wakai, M. Kubota et al., “DNA damage sensor γ-H2AX is increased in preneoplastic lesions of hepatocellular carcinoma,” The Scientific World Journal, vol. 2013, Article ID 597095, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Z. Sisi Hu, J. Xu, X. Zhu et al., “Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter,” Clinical Laboratory, vol. 60, no. 12, pp. 2031–2037, 2014. View at Google Scholar
  24. J. Galleani, C. Miranda, M. A. Pierotti, and A. Greco, “H2AX phosphorylation and kinetics of radiation-induced DNA double strand break repair in human primary thyrocytes,” Thyroid, vol. 19, no. 3, pp. 257–264, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Lassmann, H. Hänscheid, D. Gassen et al., “In vivo formation of γ-H2AX and 53BP1 DNA repair foci in blood cells after radioiodine therapy of differentiated thyroid cancer,” The Journal of Nuclear Medicine, vol. 51, no. 8, pp. 1318–1325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Doai, N. Watanabe, T. Takahashi et al., “Sensitive immunodetection of radiotoxicity after iodine-131 therapy for thyroid cancer using gamma-H2AX foci of DNA damage in lymphocytes,” Annals of Nuclear Medicine, vol. 27, no. 3, pp. 233–238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. C. E. Caldon, “Estrogen signaling and the DNA damage response in hormone dependent breast cancers,” Frontiers in Oncology, vol. 4, article 106, 2014. View at Publisher · View at Google Scholar
  28. K. Gul, D. Ozdemir, A. Dirikoc et al., “Are endogenously lower serum thyroid hormones new predictors for thyroid malignancy in addition to higher serum thyrotropin?” Endocrine, vol. 37, no. 2, pp. 253–260, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Bandi, P. Viswanathan, and S. Gupta, “Evaluation of cytotoxicity and DNA damage response with analysis of intracellular ATM signaling pathways,” Assay and Drug Development Technologies, vol. 12, no. 5, pp. 272–281, 2014. View at Publisher · View at Google Scholar
  30. C.-Y. Shen, J.-C. Yu, Y.-L. Lo et al., “Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis,” Cancer Research, vol. 60, no. 14, pp. 3884–3892, 2000. View at Google Scholar · View at Scopus
  31. S. L. Ding, L. F. Sheu, J. C. Yu et al., “Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade,” British Journal of Cancer, vol. 90, no. 10, pp. 1995–2001, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Xie, L. Y. Xu, Z. Yang et al., “Expression of gammaH2AX in various gastric pathologies and its association with Helicobacter pylori infection,” Oncology Letters, vol. 7, no. 1, pp. 159–163, 2014. View at Google Scholar
  33. L.-J. Mah, A. El-Osta, and T. C. Karagiannis, “γH2AX as a molecular marker of aging and disease,” Epigenetics, vol. 5, no. 2, pp. 129–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Zambrano, V. García-Carpizo, M. E. Gallardo et al., “The thyroid hormone receptor β induces DNA damage and premature senescence,” Journal of Cell Biology, vol. 204, no. 1, pp. 129–146, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. E. M. Abdel-Rahman, W. Mansour, and J. L. Holley, “Thyroid hormone abnormalities and frailty in elderly patients with chronic kidney disease: a hypothesis,” Seminars in Dialysis, vol. 23, no. 3, pp. 317–323, 2010. View at Publisher · View at Google Scholar · View at Scopus